{"id":"https://openalex.org/W4291493151","doi":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","title":"P-059: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 3 RESOLVE TRIAL INVESTIGATING THE EFFICACY OF VOXELOTOR WITH STANDARD OF CARE IN THE RESOLUTION OF LEG ULCERS IN PATIENTS WITH SICKLE CELL DISEASE","display_name":"P-059: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 3 RESOLVE TRIAL INVESTIGATING THE EFFICACY OF VOXELOTOR WITH STANDARD OF CARE IN THE RESOLUTION OF LEG ULCERS IN PATIENTS WITH SICKLE CELL DISEASE","publication_year":2022,"publication_date":"2022-08-01","ids":{"openalex":"https://openalex.org/W4291493151","doi":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000873128.79642.8d","doi":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016200313","display_name":"Caterina P. Minniti","orcid":"https://orcid.org/0000-0002-7059-2959","observed_orcids":["https://orcid.org/0000-0002-7059-2959"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MINNITI C.","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, UNITED STATES","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033435175","display_name":"S Bradley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117853","display_name":"Global Blood Therapeutics (United States)","ror":"https://ror.org/03cr60k70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"BRADLEY S.","raw_affiliation_strings":["Global Blood Therapeutics, South San Francisco, CA, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Blood Therapeutics, South San Francisco, CA, UNITED STATES","institution_ids":["https://openalex.org/I4210117853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079882392","display_name":"Jennifer F. Doss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117853","display_name":"Global Blood Therapeutics (United States)","ror":"https://ror.org/03cr60k70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"DOSS J.","raw_affiliation_strings":["Global Blood Therapeutics, South San Francisco, CA, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Blood Therapeutics, South San Francisco, CA, UNITED STATES","institution_ids":["https://openalex.org/I4210117853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042879660","display_name":"David. W. Purdie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117853","display_name":"Global Blood Therapeutics (United States)","ror":"https://ror.org/03cr60k70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"PURDIE D.","raw_affiliation_strings":["Global Blood Therapeutics, South San Francisco, CA, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Blood Therapeutics, South San Francisco, CA, UNITED STATES","institution_ids":["https://openalex.org/I4210117853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001812366","display_name":"Carolyn C. Hoppe","orcid":"https://orcid.org/0000-0001-9213-0547","observed_orcids":["https://orcid.org/0000-0001-9213-0547"]},"institutions":[{"id":"https://openalex.org/I4210117853","display_name":"Global Blood Therapeutics (United States)","ror":"https://ror.org/03cr60k70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"HOPPE C.","raw_affiliation_strings":["Global Blood Therapeutics, South San Francisco, CA, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Blood Therapeutics, South San Francisco, CA, UNITED STATES","institution_ids":["https://openalex.org/I4210117853"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015048170","display_name":"Andrew S. Crouch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"CROUCH A.","raw_affiliation_strings":["Albert Einstein College of Medicine, Bronx, NY, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine, Bronx, NY, UNITED STATES","institution_ids":["https://openalex.org/I129975664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12451362,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"45","last_page":"46"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12094","display_name":"Hemoglobin structure and function","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/voxelotor","display_name":"voxelotor","score":0.8040000200271606},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":1.0},{"id":"https://openalex.org/keywords/leg-ulcers","display_name":"leg ulcers","score":0.9940000176429749},{"id":"https://openalex.org/keywords/skin-ulcers","display_name":"skin ulcers","score":0.8299999833106995},{"id":"https://openalex.org/keywords/standard-of-care","display_name":"standard of care","score":0.6299999952316284},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.7419999837875366},{"id":"https://openalex.org/keywords/hemolytic-anemia","display_name":"hemolytic anemia","score":0.6809999942779541},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4309999942779541},{"id":"https://openalex.org/keywords/sub-saharan-africa","display_name":"sub-Saharan Africa","score":0.4970000088214874},{"id":"https://openalex.org/keywords/brazil","display_name":"Brazil","score":0.33899998664855957},{"id":"https://openalex.org/keywords/kenya","display_name":"Kenya","score":0.8220000267028809},{"id":"https://openalex.org/keywords/nigeria","display_name":"Nigeria","score":0.7839999794960022},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.36800000071525574},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.39399999380111694},{"id":"https://openalex.org/keywords/hope-study","display_name":"HOPE study","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8911324739456177},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5248422622680664},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5070719718933105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4902549088001251},{"id":"https://openalex.org/C2775965419","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter trial","level":4,"score":0.4792245030403137},{"id":"https://openalex.org/C2778620579","wikidata":"https://www.wikidata.org/wiki/Q185034","display_name":"Sickle cell anemia","level":3,"score":0.4583664536476135},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40267789363861084},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.355305552482605},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.34810107946395874},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3317987322807312},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.16667845845222473},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13715922832489014},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000873128.79642.8d","doi":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9429900","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9429900","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:f9aa5228d01c44d7b1f8b01d42c5d713","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f9aa5228d01c44d7b1f8b01d42c5d713","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 45-46 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000873128.79642.8d","doi":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000873128.79642.8d","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4306319740","https://openalex.org/W7222147883","https://openalex.org/W4310125633","https://openalex.org/W7214545902","https://openalex.org/W4389231412","https://openalex.org/W4389243421","https://openalex.org/W3097390986","https://openalex.org/W2950909709","https://openalex.org/W3122634507","https://openalex.org/W3214708402"],"abstract_inverted_index":{"Purpose:":[0],"Sickle":[1],"cell":[2,37],"disease":[3],"(SCD)":[4],"is":[5,24,80,147,240,272,378],"a":[6,12,142,187,195,281,329,484,503],"heritable":[7],"blood":[8,36],"disorder":[9],"caused":[10],"by":[11,102,233,397,411,446],"point":[13],"mutation":[14],"in":[15,29,106,109,112,115,118,122,127,149,157,166,178,190,215,227,260,266,324,346,407,431,472,483],"the":[16,25,44,84,128,150,153,167,170,203,251,261,299,310,354,376,381,398,461,467,479,490],"\u03b2-globin":[17],"gene.":[18],"Polymerization":[19],"of":[20,47,73,86,97,155,172,199,218,230,253,257,263,284,306,375,383,400,404,421,435,443,464,469,505],"deoxygenated":[21],"mutated":[22],"hemoglobin":[23,144],"major":[26,45],"molecular":[27],"process":[28],"SCD":[30,79,156,177,285],"pathogenesis":[31],"that":[32,308],"leads":[33],"to":[34,43,176,337,348,379,419,425,481],"red":[35],"sickling":[38],"and":[39,51,65,67,88,125,159,165,180,221,237,278,293,315,321,441,458,498],"hemolysis.":[40],"In":[41,194],"addition":[42,347],"complications":[46,57],"SCD\u2014hemolytic":[48],"anemia,":[49],"inflammation,":[50],"vascular":[52],"occlusion\u2014patients":[53],"often":[54],"experience":[55],"secondary":[56,415],"such":[58],"as":[59,186],"stroke,":[60],"organ":[61],"damage,":[62],"shortened":[63],"lifespan,":[64],"painful":[66],"debilitating":[68],"skin":[69],"ulcers.":[70,140],"The":[71,372],"prevalence":[72],"leg":[74,98,139,209,222,264,393,470],"ulcers":[75,99,210,223,265,445,471],"among":[76],"people":[77],"with":[78,132,192,255,268,280,294,388,402,474],"likely":[81],"underestimated,":[82],"given":[83],"lack":[85],"registries":[87],"large":[89],"prospective":[90],"studies":[91],"examining":[92],"this":[93,452],"complication.":[94],"Current":[95],"estimates":[96],"vary":[100],"widely":[101],"geographic":[103],"region:":[104],"43%":[105],"Brazil,":[107],"30%":[108],"Jamaica,":[110],"27%":[111],"Nigeria,":[113,276],"19%":[114],"Ghana,":[116],"13%":[117],"Sierra":[119],"Leone,":[120],"8%":[121],"Saudi":[123],"Arabia,":[124],"1%-5%":[126],"US.":[129],"Among":[130],"Americans":[131],"SCD,":[133],"an":[134,241],"estimated":[135],"14%-18%":[136],"may":[137],"develop":[138],"Voxelotor,":[141],"sickle":[143],"polymerization":[145],"inhibitor,":[146],"approved":[148],"US":[151],"for":[152,169,350,367,466],"treatment":[154,171,356,409,468,492],"adults":[158,179],"pediatric":[160,181],"patients":[161,182,201,232,267,274,401,459,473],"aged":[162,183,290],"\u22654":[163],"years":[164,185],"EU":[168],"hemolytic":[173],"anemia":[174],"due":[175],"\u226512":[184,291],"monotherapy":[188],"or":[189,225,287,304,344],"combination":[191],"hydroxycarbamide.":[193],"post":[196],"hoc":[197],"analysis":[198],"voxelotor-treated":[200],"from":[202,275,429,451],"phase":[204,243],"3":[205],"HOPE":[206],"study":[207,377,453,488],"(NCT03036813),":[208],"resolved":[211,226],"within":[212],"24":[213],"weeks":[214,369],"10":[216],"out":[217,229],"14":[219,231],"patients,":[220],"improved":[224],"13":[228],"week":[234,412,426,439,447],"72.":[235],"Materials":[236],"methods:":[238],"RESOLVE":[239,494],"ongoing":[242],"3,":[244],"randomized,":[245],"double-blind,":[246],"placebo-controlled,":[247],"multicenter":[248],"trial":[249],"investigating":[250],"efficacy":[252,382],"voxelotor":[254,341,362,384,465],"standard":[256],"care":[258],"(SOC)":[259],"resolution":[262,403,420],"SCD.":[269,475],"Target":[270],"enrollment":[271],"80":[273],"Kenya,":[277],"Brazil":[279],"confirmed":[282],"diagnosis":[283],"(HbSS":[286],"HbS\u03b20":[288],"genotype),":[289],"years,":[292],"\u22651":[295],"cutaneous":[296],"ulcer":[297,394],"on":[298,392],"lower":[300],"extremity":[301],"(leg,":[302],"ankle,":[303],"dorsum":[305],"foot)":[307],"meets":[309],"following":[311],"criteria:":[312],"\u22652":[313],"weeks\u2019":[314],"<6":[316],"months\u2019":[317],"duration":[318],"at":[319,438],"screening":[320],">2":[322],"cm2":[323],"area":[325,434],"before":[326],"randomization.":[327],"After":[328,353],"2-week":[330],"run-in":[331],"period,":[332,357],"participants":[333,359],"are":[334],"randomized":[335,355],"1:1":[336],"receive":[338,360],"once-daily":[339],"oral":[340],"1500":[342,363],"mg":[343,364],"placebo":[345,389],"SOC":[349,366,386,391],"12":[351,368],"weeks.":[352],"all":[358],"open-label":[361,486],"plus":[365,385,390],"(Figure).":[370],"Results:":[371],"primary":[373],"objective":[374],"assess":[380],"compared":[387],"healing,":[395],"measured":[396],"proportion":[399],"target":[405,422,436],"ulcer(s)":[406,423,437],"each":[408],"group":[410],"12.":[413,448],"Key":[414],"endpoints":[416],"include":[417],"days":[418],"up":[424],"12,":[427,440],"change":[428],"baseline":[430],"total":[432],"surface":[433],"incidence":[442],"new":[444],"Conclusion:":[449],"Results":[450],"will":[454,477],"further":[455],"guide":[456],"clinicians":[457],"regarding":[460],"clinical":[462],"use":[463],"Participants":[476],"have":[478],"option":[480],"enroll":[482],"separate":[485],"extension":[487],"after":[489],"24-week":[491],"period.Figure.":[493],"Study":[495],"Design,":[496],"Population,":[497],"Timeline":[499],"J.":[500],"DOSS":[501],"declares":[502],"conflict":[504],"interest:":[506],"Stock":[507],"shareholder:":[508],"Global":[509],"Blood":[510],"Therapeutics,":[511],"Roche":[512]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-08-15T00:00:00"}